BioCentury | Jan 11, 2019
Financial News

New exchange may give biotechs alternative to NASDAQ, NYSE

A new equities exchange founded by financial firms could offer biotechs a simple, low-cost alternative to NASDAQ or NYSE. The Members Exchange (MEMX), which counts BofA Merrill Lynch and Morgan Stanley among its founders, will...
BioCentury | Jan 8, 2019
Financial News

New exchange may give biotechs alternative to NASDAQ, NYSE

A new equities exchange founded by financial firms could offer biotechs a simple, low-cost alternative to NASDAQ or NYSE. The Members Exchange (MEMX), which counts BofA Merrill Lynch and Morgan Stanley among its founders, will...
Items per page:
1 - 2 of 2
BioCentury | Jan 11, 2019
Financial News

New exchange may give biotechs alternative to NASDAQ, NYSE

A new equities exchange founded by financial firms could offer biotechs a simple, low-cost alternative to NASDAQ or NYSE. The Members Exchange (MEMX), which counts BofA Merrill Lynch and Morgan Stanley among its founders, will...
BioCentury | Jan 8, 2019
Financial News

New exchange may give biotechs alternative to NASDAQ, NYSE

A new equities exchange founded by financial firms could offer biotechs a simple, low-cost alternative to NASDAQ or NYSE. The Members Exchange (MEMX), which counts BofA Merrill Lynch and Morgan Stanley among its founders, will...
Items per page:
1 - 2 of 2